(Q51722262)
Statements
1 reference
Efficacy of omalizumab, an anti-immunoglobulin E antibody, in patients with allergic asthma at high risk of serious asthma-related morbidity and mortality. (English)
1 reference
Holgate S
1 reference
Bousquet J
1 reference
Wenzel S
1 reference
Fox H
1 reference
Liu J
1 reference
Castellsague J
1 reference
1 January 2001
1 reference
17
1 reference
4
1 reference
233-240
1 reference